Search

Your search keyword '"Artico, J."' showing total 93 results

Search Constraints

Start Over You searched for: Author "Artico, J." Remove constraint Author: "Artico, J."
93 results on '"Artico, J."'

Search Results

1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

2. An accurate and time-efficient deep learning-based system for automated segmentation and reporting of cardiac magnetic resonance-detected ischemic scar

3. Myocarditis in Heart Failure

4. Sex‐ and age‐related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long‐Term Registry

5. C65 POST–DISCHARGE ARRHYTHMIC RISK STRATIFICATION OF PATIENTS WITH ACUTE MYOCARDITIS AND LIFE–THREATENING VENTRICULAR TACHYARRHYTHMIAS

6. Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors

7. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction

8. Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

9. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

11. Prospective case-control study of cardiovascular abnormalities six months following mild COVID-19 in healthcare workers

12. Myocardial perfusion after COVID-19 infection: No persisting impaired myocardial blood flow in surviving patients

13. Dark blood ischemic LGE segmentation using a deep learning approach

14. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

15. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

16. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

17. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

18. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

19. Use of quantitative myocardial perfusion mapping by CMR for characterisation of ischaemia in patients post coronary artery bypass graft surgery

21. The late-onset dilated cardiomyopathy

22. 1040 Unexpected prevalence of subtle systolic and diastolic dysfunction in genotype-positive phenotype-negative relatives of dilated cardiomyopathy patients

23. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

24. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

25. Fulminant Versus Acute Nonfulminant Myocarditis in Patients With Left Ventricular Systolic Dysfunction

26. Post-discharge arrhythmic risk stratification of patients with acute myocarditis and life-threatening ventricular tachyarrhythmias

27. Viral genome search in myocardium of patients with fulminant myocarditis

28. Persistent left ventricular dysfunction after acute lymphocytic myocarditis: Frequency and predictors

29. An accurate and time-efficient deep learning-based system for automated segmentation and reporting of cardiac magnetic resonance-detected ischemic scar

30. The curious case of a massive right heart thrombosis: a case report

31. Dark blood ischemic LGE segmentation using a deep learning approach

32. Arrhythmic risk stratification in patients with dilated cardiomyopathy and intermediate left ventricular dysfunction

33. Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together

34. Myocarditis: Which Role for Genetics?

35. The alcohol-induced cardiomyopathy: A cardiovascular magnetic resonance characterization

36. Viral presence-guided immunomodulation in lymphocytic myocarditis: an update

37. Sex Differences in the Long-term Prognosis of Dilated Cardiomyopathy

38. Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy beyond ejection fraction

39. Dilated Cardiomyopathy With Mid-Range Ejection Fraction at Diagnosis: Characterization and Natural History

40. Long-term patient satisfaction with implanted device remote monitoring: A comparison among different systems

41. Thoracic Pain: Clinical Features

42. ICD replacement in patients with intermediate left ventricular dysfunction under optimal medical treatment

43. Cardiovascular aging: the unveiled enigma from bench to bedside

44. Clinical Significance of Myocardial Injury in Patients Hospitalized for COVID-19: A Prospective, Multicenter, Cohort Study.

45. Predicting cardiovascular events with fluoropyrimidine chemotherapy using a standard cardiovascular risk calculator.

46. The future of cardiovascular magnetic resonance: All-in-one vs. real-time (Part 1).

47. Current Treatment and Immunomodulation Strategies in Acute Myocarditis.

48. Navigating the research landscape in cardiology. Part 2: finding the right research.

49. Strengths and weaknesses of alternative noninvasive imaging approaches for microvascular ischemia.

50. An accurate and time-efficient deep learning-based system for automated segmentation and reporting of cardiac magnetic resonance-detected ischemic scar.

Catalog

Books, media, physical & digital resources